Chloroform → 7-{[(1-{[(2R)-3,8-Dioxo-1,2-dihydro-3H,8H-2a,5,8a-triazaacenaphthylen-2-yl]methyl}-4-piperidinyl)amino]methyl}-2,3-dihydro-1,4-benzodioxin-5-carbonitrile hydrochloride

HRID 1943228ノート

反応式

HRID 1943228 の反応式
[NH2:1][CH:2]1[CH2:7][CH2:6][N:5]([CH2:8][C@H:9]2[N:19]3[C:20]4[N:11]([C:12](=[O:22])[CH:13]=[CH:14][C:15]=4[N:16]=[CH:17][C:18]3=[O:21])[CH2:10]2)[CH2:4][CH2:3]1.[CH:23]([C:25]1[CH:26]=[C:27]([C:35]#[N:36])[C:28]2[O:33][CH2:32][CH2:31][O:30][C:29]=2[CH:34]=1)=O.C(O[BH-](OC(=O)C)OC(=O)C)(=O)C.[Na+].C([O-])(O)=O.[Na+].C(Cl)(Cl)[Cl:57]>CO>[ClH:57].[O:21]=[C:18]1[CH:17]=[N:16][C:15]2=[C:20]3[N:19]1[C@H:9]([CH2:8][N:5]1[CH2:6][CH2:7][CH:2]([NH:1][CH2:23][C:25]4[CH:26]=[C:27]([C:35]#[N:36])[C:28]5[O:33][CH2:32][CH2:31][O:30][C:29]=5[CH:34]=4)[CH2:3][CH2:4]1)[CH2:10][N:11]3[C:12](=[O:22])[CH:13]=[CH:14]2

参加物

7

実験手順

A suspension of (2R)-2-[(4-amino-1-piperidinyl)methyl]-1,2-dihydro-3H,8H-2a,5,8a-triazaacenaphthylene-3,8-dione (for a preparation see Example 16A(j)) (60 mg, 0.199 mmol) and 7-formyl-2,3-dihydro-1,4-benzodioxin-5-carbonitrile (for a synthesis see WO06014580 Preparation 13 or WO2007122258, Example 31(d)) (37.7 mg, 0.199 mmol) in chloroform (2 ml) and methanol (0.100 ml) at room temperature under nitrogen was treated with sodium triacetoxyborohydride (127 mg, 0.597 mmol) and stirred for 90 min. This was then treated with saturated aqueous NaHCO3(10 ml) and extracted with 20% methanol/DCM (3×25 ml). The combined organic extracts were dried (NaSO4), filtered, evaporated and purified using silica chromatography (0-20% methanol/DCM) to give the free base of the title compound as a yellow gum (40 mg, 42.3%).

後処理

  1. extractionextracted with 20% methanol/DCM (3×25 ml)
  2. dry with materialThe combined organic extracts were dried (NaSO4)
  3. filtrationfiltered
  4. customevaporated
  5. custompurified

出典と根拠

ORDレコード
ord-1570d810b1ee476780e0b5594366d4ac
出典データセット
uspto-grants-2013_03
特許番号
US08389524B2

反応ノート

読み込み中…